APA (7th ed.) Citation

C, A., LT, B., CT, F., S, H., H, K., L, H., . . . M, R. (2022). Correction: Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism. Endocrine, 75(1), 312. https://doi.org/10.1007/s12020-021-02905-9

Chicago Style (17th ed.) Citation

C, Adolf, et al. "Correction: Spironolactone Reduces Biochemical Markers of Bone Turnover in Postmenopausal Women with Primary Aldosteronism." Endocrine 75, no. 1 (2022): 312. https://doi.org/10.1007/s12020-021-02905-9.

MLA (9th ed.) Citation

C, Adolf, et al. "Correction: Spironolactone Reduces Biochemical Markers of Bone Turnover in Postmenopausal Women with Primary Aldosteronism." Endocrine, vol. 75, no. 1, 2022, p. 312, https://doi.org/10.1007/s12020-021-02905-9.